Q32 Bio Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -167.4% | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | -0.8% | -1.6% | +1.7% | -2.4% | -0.8% | -23.5% | +0.0% | -1.1% | -63.3% | +330.3% | – | |
| – | +38.5% | +0.0% | +220.4% | +3.4% | -9.5% | +7.3% | -5.5% | -7.3% | +24.9% | +5.4% | +8.9% | – | |
| – | -38.0% | -104.0% | – | – | – | -328.4% | – | – | -111.3% | – | – | – | |
| – | -100.0% | – | – | +286.7% | -96.6% | -100.0% | – | -100.0% | – | – | – | – | |
| – | – | -99.7% | +10,093.8% | +0.5% | -100.0% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | -0.1% | +0.1% | +428.3% | – | |
| – | -74.7% | +130,618.4% | -105.6% | – | -68.2% | -100.0% | – | +393.1% | -0.1% | – | +566.1% | – | |
| – | – | – | -121.0% | – | – | – | – | – | – | – | +2,162.4% | – | |
| – | -167.4% | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.